BioRestorative Therapies, Inc. (BRTX) News
Track canonical SquawkNews coverage tagged to BRTX, BioRestorative Therapies, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
BioRestorative Therapies Inc expected to post loss
BioRestorative Therapies Inc is anticipated to report a loss of $2.50 per share.
EARNINGS | Oct 02, 2026, 11:01 AM UTC
L
BioRestorative Therapies expected loss of 12 cents/share
BioRestorative Therapies Inc is expected to post a loss of 12 cents a share in upcoming earnings.
EARNINGS | Sep 04, 2026, 11:04 AM UTC
L
BioRestorative Therapies board approves 1-for-20 reverse split for BRTX
BioRestorative Therapies’ board approved a 1-for-20 reverse split for BRTX.
EQUITY | Sep 02, 2026, 09:30 PM UTC
L
BioRestorative names interim CEO, appoints CFO
BioRestorative Therapies appointed Mika Grasso as interim chief executive officer and Anna Skowron as chief financial officer. Katharyn Field stepped aside from her interim roles and resigned from the board.
REGULATION | Sep 02, 2026, 10:04 AM UTC
M
BRTX Completes BRTX-100 Phase 2
BioRestorative Therapies completes BRTX-100 Phase 2 manufacturing, highlighting its integrated regenerative biologics platform
EQUITY | Jun 25, 2026, 12:15 PM UTC